Page 180 - 2023 SMOG Digital
P. 180

TRANEXAMIC ACID     B Lactation: Yes(Caution)  Trade Name: Cyklokapron/Lysteda
             Class / Mechanism of Action
             Antifibrinolytic Agent, Hemostatic Agent
             Displaces plasminogen from fibrin resulting in inhibition of fibrinolysis and inhibits the proteolytic activity of
             plasmin
             Indications:
             •  Trauma-associated hemorrhage: Casualty likely needing blood transfusion (hemorrhagic shock,
               elevated lactate, one or more major amputations, penetrating torso trauma, or evidence of severe
               bleeding)
             •  Post-Operative Hemorrhage by dissection, enteric staples or suspected internal bleeding
             •  Signs or symptoms of significant TBI or altered mental status associated with blast or blunt trauma
             •  Postpartum Hemorrhage (continued bleeding despite Oxytocin and fundal massage)
             Contraindications
             •  TXA is contraindicated in trauma if dose is not given within first 3 hours following Traumatic
               event (Ideal dosing time-frame is within 1 hour of trauma)
             •  Hypersensitivity to tranexamic
             •  Subarachnoid hemorrhage
             •  Thromboembolic disease (Cerebral Thrombosis, DVT, PE)
             Adverse Reactions / Precautions
             •  Disseminated intravascular coagulation (DIC): Use with extreme caution in patients with DIC requiring
               antifibrinolytic therapy; patients should be under strict supervision of a physician experienced in
               treating this disorder. TXA should be used in Pt.'s with trauma related DIC however.
             •  Thrombosis (especially when given after 3hr from injury)
             •  Seizure
             Dose and Administration:    ADULT    PEDIATRIC Always Reference BROSELOW Tape
             Trauma-associated hemorrhage (unlabeled   Trauma-associated hemorrhage (unlabeled
             use):                       use):
             IV:                         IV:
             •  Initial Dose: 2g TXA in 100cc NS or LR ASAP   •  Initial Dose: 15mg/kg via IV/IO Bolus (goal
               via IV/IO Bolus, or 2g IV/IO push (1g over 1min   within 1 minute),
               per push) but NOT later than 3 hours after
               injury.
             •  If patient received 1g of TXA prior and
               <3hr from time of injury: 1g TXA IV/IO push
               over 1 minute or mixed in 100cc NS or LR
               Bolus. If >3hr from time of injury: DO NOT
               administer TXA.
             Suspected Post-Operative Hemorrhage by
             dissection, enteric staples or suspected
             internal bleeding:
             •  Initial Dose: 2g of TXA in 100cc NS or LR
               ASAP via IV/IO Bolus or 2g IV/IO push (1g over
               1 minute push) but NOT later than 3 hours after
               start of suspected hemorrhage.




        180
   175   176   177   178   179   180   181   182   183   184   185